Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTPN1 | P18031 | 1/20 | 0.32 |
| ▸ | ACP1 | P24666 | 1/20 | 0.32 |
| ▸ | CDC25B | P30305 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.32 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.32 |
| ▸ | MAPT | P10636 | 1/20 | 0.32 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.32 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.32 |
| ▸ | PPARG | P37231 | 2/20 | 0.32 |
| ▸ | PPARA | Q07869 | 2/20 | 0.32 |
| ▸ | DNTT | P04053 | 2/20 | 0.31 |
| ▸ | POLB | P06746 | 2/20 | 0.31 |
| ▸ | POLA1 | P09884 | 2/20 | 0.31 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.31 |
| ▸ | NLRP3 | Q96P20 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4075689 | 0.94 | PTPN1 (0.35) | PTPN1ACP1CDC25BALDH1A1CYP3A4 | |
| SCHEMBL4072145 | 0.89 | PTPN1 (0.33) | PTPN1ACP1CDC25BALDH1A1CYP3A4 | |
| SCHEMBL9964234 | 0.79 | NLRP3 (0.35) | CYP3A4CYP2C19NLRP3 | |
| SCHEMBL4067956 | 0.62 | NLRP3 (0.38) | ALDH1A1CYP3A4MAPTCYP2C19HSD17B10 | |
| Heptane SCHEMBL1680974 | 0.59 | ALDH1A1 (0.74) | ALDH1A1MAPTHSD17B10 | |
| Heptane SCHEMBL1614041 | 0.59 | ALDH1A1 (0.74) | ALDH1A1MAPTHSD17B10 | |
| Heptane SCHEMBL1190938 | 0.59 | ALDH1A1 (0.74) | ALDH1A1MAPTHSD17B10 | |
| Heptane SCHEMBL15345911 | 0.59 | ALDH1A1 (0.74) | ALDH1A1MAPTHSD17B10 | |
| Heptane SCHEMBL18725336 | 0.59 | ALDH1A1 (0.74) | ALDH1A1MAPTHSD17B10 | |
| Dodecane SCHEMBL3308504 | 0.59 | ALDH1A1 (0.74) | ALDH1A1MAPTHSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8309507-B2 | Processes for making fluid detergent compositions comprising a di-amido gellant | THE PROCTER & GAMBLE COMPANY (US) | 2012-11-13 | — | — | US | disclosed |
| US-8207107-B2 | Di-amido gellant for use in consumer product compositions | THE PROCTER & GAMBLE COMPANY (US) | 2012-06-26 | — | — | US | disclosed |
| US-20120151881-A1 | PROCESSES FOR MAKING FLUID DETERGENT COMPOSITIONS COMPRISING A DI-AMIDO GELLANT | FERNANDEZ PRIETO SUSANA (ES) | 2012-06-21 | — | — | US | disclosed |
| US-20110224455-A1 | Di-Amido Gellant For Use In Consumer Product Compositions | THE PROCTER & GAMBLE COMPANY | 2011-09-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110224455-A1 | Di-Amido Gellant For Use In Consumer Product Compositions | DAGLA, GNPAT, CDIPT | PTPN1 3132/4885ACP1 1931/4885CDC25B 4006/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.